Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cerus Corp (CERS)

Cerus Corp (CERS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 395,701
  • Shares Outstanding, K 192,088
  • Annual Sales, $ 201,320 K
  • Annual Income, $ -20,920 K
  • EBIT $ -9 M
  • EBITDA $ -8 M
  • 60-Month Beta 1.55
  • Price/Sales 2.20
  • Price/Cash Flow N/A
  • Price/Book 6.36

Options Overview Details

View History
  • Implied Volatility 154.75% (-150.02%)
  • Historical Volatility 73.95%
  • IV Percentile 58%
  • IV Rank 20.27%
  • IV High 588.50% on 04/10/25
  • IV Low 44.51% on 06/06/25
  • Expected Move (DTE 21) 0.41 (19.81%)
  • Put/Call Vol Ratio 999.99
  • Today's Volume 2
  • Volume Avg (30-Day) 179
  • Put/Call OI Ratio 0.06
  • Today's Open Interest 3,887
  • Open Int (30-Day) 7,673
  • Expected Range 1.65 to 2.47

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.01
  • Number of Estimates 1
  • High Estimate -0.01
  • Low Estimate -0.01
  • Prior Year -0.01
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.67 +23.35%
on 11/25/25
2.26 -8.85%
on 12/17/25
+0.37 (+21.89%)
since 11/24/25
3-Month
1.38 +49.28%
on 11/06/25
2.26 -8.85%
on 12/17/25
+0.52 (+33.77%)
since 09/24/25
52-Week
1.12 +83.93%
on 04/07/25
2.26 -8.85%
on 12/17/25
+0.48 (+30.38%)
since 12/24/24

Most Recent Stories

More News
Cerus Corporation Announces Group Purchasing Agreement with Blood Centers of America

Cerus Corporation (Nasdaq: CERS) announced today that it has entered into a group purchasing agreement with Blood Centers of America (BCA), the largest blood supply cooperative in the U.S. BCA member blood...

CERS : 2.06 (unch)
Cerus: Q3 Earnings Snapshot

Cerus: Q3 Earnings Snapshot

CERS : 2.06 (unch)
Cerus Corporation Announces Record Results for Third Quarter 2025 and Raises Full Year 2025 Product Revenue Guidance

Third Quarter Total Revenue up 19% to $60.2 Million; Record Product Revenue of $52.7 Million, Up 15% Year-Over-Year Raising Full-Year 2025 Product Revenue Guidance Range...

CERS : 2.06 (unch)
Cerus Corporation Announces Abstracts and Industry Workshop on IFC at the 2025 AABB Annual Meeting

Cerus Corporation (Nasdaq: CERS) announced today that it will host an industry workshop on the benefits of Pathogen Reduced Cryoprecipitated Fibrinogen Complex, commonly referred to as INTERCEPT Fibrinogen...

CERS : 2.06 (unch)
Cerus Corporation to Release Third Quarter 2025 Financial Results on November 6, 2025

Cerus Corporation (Nasdaq: CERS) announced today that its third quarter 2025 financial results will be released on Thursday, November 6, 2025, after the close of the stock market. The Company will host...

CERS : 2.06 (unch)
The German National Blood Advisory Committee Issues Formal Recommendation for Improving the Safety of Platelet Transfusions

Cerus Corporation (Nasdaq: CERS) announced today the publication of a new recommendation from the German National Blood Advisory Committee (Arbeitskreis Blut or AK Blut), which recommends proactive measures,...

CERS : 2.06 (unch)
Cerus Corporation to Participate in the Cantor Global Healthcare Conference 2025

Cerus Corporation (Nasdaq: CERS) announced today that company management will participate in a fireside chat at the Cantor Global Healthcare Conference 2025 on Wednesday, September 3, 2025, at 10:55 A.M....

CERS : 2.06 (unch)
Cerus: Q2 Earnings Snapshot

Cerus: Q2 Earnings Snapshot

CERS : 2.06 (unch)
Cerus Corporation Announces Second Quarter 2025 Financial Results

Second Quarter Total Revenue of $60.1 Million; Record Product Revenue of $52.4 Million, Up 16% Year-Over-Year Raising Full-Year 2025 Product...

CERS : 2.06 (unch)
Cerus Corporation to Release Second Quarter 2025 Financial Results on August 5, 2025

Cerus Corporation (Nasdaq: CERS) announced today that its second quarter 2025 financial results will be released on Tuesday, August 5, 2025, after the close of the stock market. The Company will host a...

CERS : 2.06 (unch)

Business Summary

Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company...

See More

Key Turning Points

3rd Resistance Point 2.14
2nd Resistance Point 2.10
1st Resistance Point 2.08
Last Price 2.06
1st Support Level 2.03
2nd Support Level 1.99
3rd Support Level 1.97

See More

52-Week High 2.26
Last Price 2.06
Fibonacci 61.8% 1.82
Fibonacci 50% 1.69
Fibonacci 38.2% 1.56
52-Week Low 1.12

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar